GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TaiwanJ Pharmaceuticals Co 6549.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

6.25

+3.48%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−TWD 24.3m

FY2016FY2025

Free cash flow

−TWD 24.5m

FY2016FY2025

Shareholders' equity

TWD 70.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue——TWD 22.7mTWD 15.4mTWD 22.1m—TWD 61.7m———
Research and developmentTWD 10.7mTWD 10.3mTWD 14.0mTWD 12.7mTWD 17.7mTWD 26.0mTWD 26.1mTWD 90.9mTWD 165.1mTWD 202.3m
Operating income−TWD 25.2m−TWD 27.0m−TWD 6.6m−TWD 96.4m−TWD 9.7m−TWD 42.4m−TWD 6.7m−TWD 111.4m−TWD 187.0m−TWD 227.8m
Net income−TWD 24.3m−TWD 22.3m−TWD 6.0m−TWD 92.5m−TWD 12.4m−TWD 42.5m−TWD 5.1m−TWD 238.2m−TWD 186.0m−TWD 222.8m
Diluted earnings per share-0.30-0.29-0.08-1.23-0.17-0.60-0.07-3.50-3.39-4.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 77.2mTWD 100.8mTWD 73.6mTWD 79.8mTWD 170.3mTWD 183.2mTWD 159.9mTWD 165.3mTWD 319.0mTWD 306.3m
Cash and short-term investments—TWD 87.6mTWD 58.8mTWD 60.7mTWD 82.9mTWD 93.4mTWD 12.2mTWD 57.6mTWD 78.6mTWD 59.7m
Total liabilitiesTWD 6.3mTWD 5.7mTWD 6.6mTWD 8.2mTWD 6.9mTWD 7.3mTWD 8.2mTWD 10.9mTWD 28.6mTWD 22.7m
Debt—TWD 472,000TWD 1.2mTWD 1.9mTWD 331,000TWD 890,000TWD 890,000———
Shareholders' equityTWD 70.9mTWD 95.1mTWD 66.9mTWD 71.6mTWD 163.5mTWD 175.9mTWD 151.7mTWD 154.3mTWD 290.4mTWD 283.6m
Shares outstanding80m78m75m75m75m71m69m68m55m50m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 24.2m−TWD 22.6m−TWD 821,000−TWD 21.1m−TWD 10.0m−TWD 41.3mTWD 16.9m−TWD 117.7m−TWD 174.5m−TWD 201.7m
Capital spending−TWD 286,000—−TWD 1.4m−TWD 1.2m—−TWD 1.4m−TWD 1.5m−TWD 315,000—−TWD 185,000
Free cash flow−TWD 24.5m−TWD 22.6m−TWD 2.3m−TWD 22.3m−TWD 10.0m−TWD 42.7mTWD 15.4m−TWD 118.0m−TWD 174.5m−TWD 201.8m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue————TWD 22.7mTWD 15.4m—TWD 11.0m
Operating income−TWD 11.7m−TWD 13.5m−TWD 6.7m−TWD 18.9mTWD 12.3m−TWD 84.6mTWD 2.9m−TWD 5.2m
Net income−TWD 12.7m−TWD 12.7m−TWD 4.8m−TWD 18.1mTWD 12.0m−TWD 82.9m−TWD 9.5m−TWD 6.2m
Diluted earnings per share-0.16-0.16-0.06-0.240.16-1.10-0.13-0.08
Cash from operations−TWD 11.0m−TWD 10.0m−TWD 9.0m−TWD 14.0mTWD 14.0m−TWD 8.0m—−TWD 5.0m
Capital spending————−TWD 1.0m−TWD 1.0m——
Free cash flow————TWD 13.0m−TWD 9.0m——
Total assetsTWD 88.2mTWD 100.8mTWD 62.4mTWD 73.6mTWD 88.8mTWD 79.8m—TWD 170.3m
Cash and short-term investmentsTWD 73.4mTWD 87.6mTWD 48.6mTWD 58.8mTWD 74.7mTWD 60.7m—TWD 82.9m
DebtTWD 1.5mTWD 944,000TWD 1.4mTWD 1.4mTWD 693,000TWD 688,000—TWD 331,000
Shareholders' equityTWD 82.6mTWD 95.1mTWD 57.4mTWD 66.9mTWD 84.3mTWD 71.6m—TWD 163.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-36.0%-9.9%-16.5%
Net income-35.9%-10.5%-16.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-25.0-28.2-180.1-8.6-59.7-21.9-157.3-1.9-3.3-4.7
Price to sales——47.951.933.6—13.0———

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.